A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0.870. It has been cited 329 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.870
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: U54 CA151880
National Institutes of Health
Grant: 199091
National Institutes of Health
Grant: R01CA208783
National Institutes of Health
Grant: R01NS102669
National Institutes of Health
Grant: R01LM011297
National Institutes of Health
Grant: F32CA216996
NIH Clinical Center
Grant: S10OD020118
U.S. Department of Energy
Grant: DE-AC02-06CH11357
NIH Clinical Center
Grant: SP0007167
NIH Clinical Center
Grant: U54CA199091
NIH Clinical Center
Grant: P50CA221747
FWCI
15.18
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals